1) Hudes G, Carducci M, Tomczak P, et al.: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356 : 2271-2281, 2007
2) Voss MH, Molina AM and Motzer RJ : mTOR inhibitors in advanced renal cell carcinoma. Hematol Oncol Clin North Am 25 : 835-852, 2011
3) Dazert E and Hall MN : mTOR signaling in disease. Curr Opin Cell Biol 23 : 744-755, 2011
4) Hutson TE, Figlin RA, Kuhn JG, et al.: Targeted therapies for metastatic renal cell carcinoma : an overview of toxicity and dosing strategies. Oncologist 13 : 1084-1096, 2008
5) Eisen T, Sternberg CN, Robert C, et al.: Targeted therapies for renal cell carcinoma : review of adverse event management strategies. J Natl. Cancer Inst 104: 93-113, 2012